Response Genetics, Inc
RGDXQ · OTC
3/31/2015 | 12/31/2014 | 9/30/2014 | 6/30/2014 | |
|---|---|---|---|---|
| Market Cap | $17,070 | $12,280 | $26,532 | $35,634 |
| - Cash | $1,735 | $2,222 | $5,959 | $2,137 |
| + Debt | $10,943 | $9,668 | $9,657 | $1,696 |
| Enterprise Value | $26,279 | $19,726 | $30,230 | $35,194 |
| Revenue | $3,791 | $4,079 | $4,465 | $4,281 |
| % Growth | -7.1% | -8.6% | 4.3% | – |
| Gross Profit | $1,476 | $1,635 | $1,922 | $1,695 |
| % Margin | 38.9% | 40.1% | 43.1% | 39.6% |
| EBITDA | -$3,449 | -$2,858 | -$3,150 | -$2,887 |
| % Margin | -91% | -70.1% | -70.5% | -67.4% |
| Net Income | -$4,204 | -$3,575 | -$3,903 | -$3,162 |
| % Margin | -110.9% | -87.6% | -87.4% | -73.9% |
| EPS Diluted | -0.11 | -0.092 | -0.1 | -0.082 |
| % Growth | -19.3% | 7.8% | -22.5% | – |
| Operating Cash Flow | -$1,880 | -$3,719 | -$4,302 | -$3,184 |
| Capital Expenditures | -$2 | -$18 | $60 | -$90 |
| Free Cash Flow | -$1,883 | -$3,737 | -$4,242 | -$3,275 |